Literature DB >> 408268

Activation of complement by opportunist pathogens and chemotypes of Salmonella minnesota.

A B Bjornson, H S Bjornson.   

Abstract

Washed cells of Staphylococcus aureus, Escherichia coli, Proteus mirabilis, Pseudomonas aeruginosa, and Salmonella minnesota chemotypes (S, Rb, and Re) were tested for their ability to activate the alternative complement pathway (ACP). Parameters of ACP activation were (i) conversion of C3 in 10 mM ethyleneglycol-bis-(beta-aminoethyl ether)-N,N1-tetraacetic acid-treated human serum supplemented with 2.5 mM MgCl2, (ii) lysis of glutathione-treated human erythrocytes in the presence of human serum, and (iii) C3 to C9 consumption in C4-deficient guinea pig serum. With the exception of S. minnesota Re and S. aureus, all of the strains were highly active in the test systems when compared with inulin. S. minnesota Re and S. aureus initiated C3 conversion in untreated human serum, suggesting that these microorganisms were capable of activating complement by a mechanism other than the ACP. These results provide direct evidence for ACP activation by opportunist gram-negative bacilli and refute the hypothesis that the lipid A moiety of the lipopolysaccharide cell wall is responsible for ACP activation.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 408268      PMCID: PMC421025          DOI: 10.1128/iai.16.3.748-753.1977

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  30 in total

1.  ROUGH MUTANTS OF SALMONELLA TYPHIMURIUM. II. SEROLOGICAL AND CHEMICAL INVESTIGATIONS.

Authors:  I BECKMANN; T V SUBBAIAH; B A STOCKER
Journal:  Nature       Date:  1964-03-28       Impact factor: 49.962

2.  ROUGH MUTANTS OF SALMONELLA TYPHIMURIUM. III. ENZYMATIC SYNTHESIS OF NUCLEOTIDE-SUGAR COMPOUNDS.

Authors:  H NIKAIDO; K MIKAIDO; T V SUBBAIAH; B A STOCKER
Journal:  Nature       Date:  1964-03-28       Impact factor: 49.962

3.  Bacteremia due to gram-negative bacilli other than the Salmonella; a clinical and therapeutic study.

Authors:  B A WAISBREN
Journal:  AMA Arch Intern Med       Date:  1951-10

4.  "Protein A" from Staphylococcus aureus. 3. Reaction with rabbit gamma-globulin.

Authors:  A Forsgren; J Sjöquist
Journal:  J Immunol       Date:  1967-07       Impact factor: 5.422

5.  "Protein A" from S. aureus. I. Pseudo-immune reaction with human gamma-globulin.

Authors:  A Forsgren; J Sjöquist
Journal:  J Immunol       Date:  1966-12       Impact factor: 5.422

6.  Activation of complement by endotoxin: a role for 2 globulin, C1, C4 and C2 in the consumption of terminal complement components by endotoxin-coated erythrocytes.

Authors:  J K Phillips; R Snyderman; S E Mergenhagen
Journal:  J Immunol       Date:  1972-08       Impact factor: 5.422

7.  Plasma kallikrein and Hageman factor in Gram-negative bacteremia.

Authors:  J W Mason; U Kleeberg; P Dolan; R W Colman
Journal:  Ann Intern Med       Date:  1970-10       Impact factor: 25.391

8.  Activation of the classical and properdin pathways of complement by bacterial lipopolysaccharides (LPS).

Authors:  D C Morrison; L F Kline
Journal:  J Immunol       Date:  1977-01       Impact factor: 5.422

9.  Isolation and properties of a surface antigen of Staphylococcus aureus.

Authors:  S I MORSE
Journal:  J Exp Med       Date:  1962-02-01       Impact factor: 14.307

10.  Studies on the chemistry and immunochemistry of cell walls of Staphylococcus aureus.

Authors:  S I MORSE
Journal:  J Exp Med       Date:  1962-08-01       Impact factor: 14.307

View more
  14 in total

1.  Anaerobic growth of Salmonella typhimurium results in increased uptake by Henle 407 epithelial and mouse peritoneal cells in vitro and repression of a major outer membrane protein.

Authors:  D A Schiemann; S R Shope
Journal:  Infect Immun       Date:  1991-01       Impact factor: 3.441

2.  Effect of topical applications of heavy suspensions of killed Malassezia ovalis on rabbit skin.

Authors:  E W Rosenberg; P Belew; G Bale
Journal:  Mycopathologia       Date:  1980-11-28       Impact factor: 2.574

3.  Activation of the alternative pathway of complement by Malassezia ovalis (Pityrosporum ovale).

Authors:  P W Belew; E W Rosenberg; B R Jennings
Journal:  Mycopathologia       Date:  1980-03-31       Impact factor: 2.574

4.  Plasmid-associated resistance of Salmonella typhimurium to complement activated by the classical pathway.

Authors:  J L Vandenbosch; D K Rabert; G W Jones
Journal:  Infect Immun       Date:  1987-11       Impact factor: 3.441

5.  Interaction of lipopolysaccharides and lipid A with complement in rats and its relation to endotoxicity.

Authors:  M A Freudenberg; C Galanos
Journal:  Infect Immun       Date:  1978-03       Impact factor: 3.441

6.  Antibody-independent interaction of the first component of complement with Gram-negative bacteria.

Authors:  M Loos; B Wellek; R Thesen; W Opferkuch
Journal:  Infect Immun       Date:  1978-10       Impact factor: 3.441

7.  Effect of dietary essential amino acid limitations upon native levels of murine serum immunoglobulins, transferrin, and complement.

Authors:  T M Petro; J K Bhattacharjee
Journal:  Infect Immun       Date:  1980-02       Impact factor: 3.441

8.  Composition and antigenic activity of the oligosaccharide moiety of Haemophilus influenzae type b lipooligosaccharide.

Authors:  T J Inzana; W E Seifert; R P Williams
Journal:  Infect Immun       Date:  1985-05       Impact factor: 3.441

9.  Role of Escherichia coli K capsular antigens during complement activation, C3 fixation, and opsonization.

Authors:  W C Van Dijk; H A Verbrugh; M E van der Tol; R Peters; J Verhoef
Journal:  Infect Immun       Date:  1979-08       Impact factor: 3.441

10.  Role of lipopolysaccharide in opsonization and phagocytosis of Pseudomonas aeruginosa.

Authors:  W Engels; J Endert; M A Kamps; C P van Boven
Journal:  Infect Immun       Date:  1985-07       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.